Melissa Griffith
Family · Amarillo, TXNPI 1275607178
Payments from drug & device makers
Across 322 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Amgen$1K
- GSK$890
- AbbVie$296
- Blueprint Medicines Corporation$295
- UCB, Inc.$215
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 38 | $1,592 |
| Amgen(2 entities) | 71 | $1,191 |
| GSK | 63 | $890 |
| AbbVie | 19 | $296 |
| Blueprint Medicines Corporation | 12 | $295 |
| UCB, Inc. | 12 | $215 |
| ANI Pharmaceuticals, Inc. | 10 | $209 |
| E.r. Squibb & Sons, L.L.C. | 19 | $197 |
| Mallinckrodt Hospital Products Inc. | 3 | $184 |
| Johnson & Johnson | 10 | $166 |
| Mylan Specialty L.p. | 9 | $139 |
| Lundbeck LLC | 2 | $125 |
| Boehringer Ingelheim | 5 | $121 |
| Novartis | 5 | $93 |
| Pfizer | 5 | $90 |
| Sobi, Inc | 5 | $87 |
| Actelion Pharmaceuticals US, Inc. | 3 | $68 |
| Sanofi | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $60 |
| Genentech USA, Inc. | 5 | $49 |
| Tactile Systems Technology Inc | 1 | $43 |
| Pharming Healthcare, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Grifols USA, LLC | 1 | $35 |
| Tonix Medicines, Inc. | 1 | $31 |
| Biocryst US Sales Co., LLC | 2 | $31 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 2 | $25 |
| Abbott | 1 | $24 |
| Avanos Medical | 1 | $22 |
| Optinose US, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Organon | 1 | $15 |
| Sandoz | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,523 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 25 | $166,477 |
| Orencia ClickjectAbatacept | 15 | $151,860 |
| Humira(Cf)Adalimumab | 15 | $125,966 |
| OrenciaAbatacept | 13 | $69,293 |
| Xeljanz XrTofacitinib Citrate | 12 | $64,639 |
| OtezlaApremilast | 13 | $60,380 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $54,677 |
| Hydroxychloroquine Sulfate | 304 | $12,002 |
| RasuvoMethotrexate/Pf | 12 | $11,812 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $10,243 |
| Modafinil | 11 | $9,108 |
| DuleraMometasone/Formoterol | 14 | $4,482 |
| MovantikNaloxegol Oxalate | 11 | $4,440 |
| Pregabalin | 186 | $3,814 |
| MethotrexateMethotrexate Sodium | 159 | $3,471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Humira(Cf) | $296 | $292,44340 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $197 | $69,29313 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $890 | $64,921109 claims |
| AmgenOtezla | $1,191 | $60,38013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Amarillo
- Kyla BeedyAmarillo$54K
- Tiffany RandleAmarillo$50K
- Cory PickettAmarillo$34K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.